Robert J. Straka

The Clinical Pharmacogenetics Implementation Consortium Guideline for <i>SLCO1B1</i>, <i>ABCG2</i>, and <i>CYP2C9</i> genotypes and Statin‐Associated Musculoskeletal Symptoms

Rhonda M. Cooper‐DeHoff, Mikko Niemi, Laura B. Ramsey et al. · Clinical Pharmacology & Therapeutics · 2022 · 296 citations · Full text

Metabolomic profiling of 17 bile acids in serum from patients with primary biliary cirrhosis and primary sclerosing cholangitis: A pilot study

Jocelyn Trottier, Andrzej Białek, Patrick Caron et al. · Digestive and Liver Disease · 2011 · 152 citations

Hepatology, Biochemistry, Biliary Tract +14

Patient Self‐Reporting of Compliance Does Not Correspond with Electronic Monitoring: An Evaluation Using Isosorbide Dinitrate as a Model Drug

Robert J. Straka, Jeffrey Fish, Steven R. Benson et al. · Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy · 1997 · 134 citations · Full text

The −256T&amp;gt;C Polymorphism in the Apolipoprotein A-II Gene Promoter Is Associated with Body Mass Index and Food Intake in the Genetics of Lipid Lowering Drugs and Diet Network Study

Dolores Corella, Donna K. Arnett, Michael Y. Tsai et al. · Clinical Chemistry · 2007 · 121 citations

Fenofibrate Effect on Triglyceride and Postprandial Response of Apolipoprotein A5 Variants

Chao‐Qiang Lai, Donna K. Arnett, Dolores Corella et al. · Arteriosclerosis Thrombosis and Vascular Biology · 2007 · 114 citations